The frequency and distribution of mutations in Plasmodium falciparum, dihydrofolate reductase and dihydropteroate synthase genes were analyzed, using the polymerase chain reaction and restriction fragment length polymorphism methodology, in infected blood samples from Mozambican children living in Maputo, before and seven days after treatment with sulfadoxine/pyrimethamine (S/P). The results showed the occurrence of point mutations in the genes studied and the presence of combinations of three alleles in dhfr (51Ile, 59Arg and 108Asn) and "quintuple" mutant (dhfr 51Ile, 59Arg, 108Asn and dhps 437Gly, 540Glu). Both of these situations were associated with seven-day therapeutic failure, following treatment with S/P. These findings show the importance of studying S/P resistance in Mozambique, and how molecular markers for antimalarial resistance can provide important data for national malaria control policy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0037-86822007000400015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
Lancet Infect Dis
March 2023
Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. Electronic address:
Article Synopsis
- - Seasonal malaria chemoprevention is implemented in 13 Sahel countries to protect children under 5 from malaria, but drug resistance is a growing concern for its effectiveness.
- - Community surveys conducted in Burkina Faso, Chad, Guinea, Mali, Nigeria, Niger, and The Gambia analyzed blood samples from children and young adults to detect P. falciparum and identify drug resistance-associated genetic variations.
- - Results showed a significant decrease in malaria prevalence among children under 5 from 2016 to 2018, with no strong evidence indicating increased drug resistance to amodiaquine or sulfadoxine-pyrimethamine in the sampled populations.
Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Acta Trop
December 2013
Department of Biology, College of Natural Sciences, Wollo University, Dessie, Ethiopia. Electronic address:
Ethiopia changed the first-line anti-malarial drug for uncomplicated Plasmodium falciparum malaria from sulfadoxine-pyrimethamine (SP) to Coartem(®) in 2004 following nation-wide assessment of the efficacy of both drugs in 2003. This study was conducted to assess the prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of P. falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
View Article and Find Full Text PDF[Sulfadoxine-pyrimethamine resistance in Maputo, Mozambique: presence of mutations in the dhfr and dhps genes of Plasmodium falciparum].
Rev Soc Bras Med Trop
February 2008
Departamento de Pediatria, Faculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Moçambique.
The frequency and distribution of mutations in Plasmodium falciparum, dihydrofolate reductase and dihydropteroate synthase genes were analyzed, using the polymerase chain reaction and restriction fragment length polymorphism methodology, in infected blood samples from Mozambican children living in Maputo, before and seven days after treatment with sulfadoxine/pyrimethamine (S/P). The results showed the occurrence of point mutations in the genes studied and the presence of combinations of three alleles in dhfr (51Ile, 59Arg and 108Asn) and "quintuple" mutant (dhfr 51Ile, 59Arg, 108Asn and dhps 437Gly, 540Glu). Both of these situations were associated with seven-day therapeutic failure, following treatment with S/P.
View Article and Find Full Text PDFAntifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Mol Biochem Parasitol
August 1998
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA.
Two new dihydrofolate reductase (DHFR) mutations were recently discovered in Plasmodium falciparum samples from an area of Bolivia with high rates of in vivo resistance to pyrimethamine-sulfadoxine: a Cys-->Arg point mutation in codon 50 and a five amino acid insertion after codon 30, termed the Bolivia repeat. We used a yeast expression system to screen these new DHFR mutants, as well as all of the other known DHFR mutant genotypes, against four antifolates: pyrimethamine, cycloguanil, chlorcycloguanil, and WR99210. The prodrug proguanil was also evaluated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!